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Abstract
Objectives: The applicability of European system for cardiac operative risk evaluation II (EuroSCORE II) and the
Society of Thoracic Surgeons Predicted Risk Of Mortality (STS-PROM) as well as the initial logistic Parsonnet risk score,
who have been developed from European and American datasets, is questionable outside these regions. We aimed to
assess the performance of these three risk scores for patients undergoing isolated coronary artery bypass grafting
(CABG) in Algeria.
Methods: Between June 2014 and June 2016, data from 235 consecutive patients, who underwent isolated CABG at a
reference center in Algiers, were prospectively collected and scored according to the EuroSCORE II, STS-PROM and the
Parsonnet score. Their discriminative power was evaluated by the area under the receiver operating characteristic curve
(AUC) while their calibration was tested by the HosmereLemeshow goodness-of-ﬁt test.
Results: The mean patient age was 59.08 years and 18.3% were female. The mortality at 30 days was 3.40%. The
mortality expected by EuroSCORE II, STS-PROM and by Parsonnet risk score was: 1.33%, 0.78% and 3.35%, respectively.
Discriminatory ability was fair for the Parsonnet risk score, good for the STS PROM and excellent for EuroSCORE II
(AUCs ¼ 0.737, 0.788, and 0.892, respectively). Regarding calibration, EuroSCORE II and STS-PROM under estimated
observed mortality (HosmereLemeshow test: P˂ 0.001 for both scores), while the Parsonnet risk score was well calibrated
(HosmereLemeshow test: p ¼ 0.395).
Conclusions: EuroSCORE II and STS-PROM had excellent and good discriminating power, respectively, but both
underestimated the risk of 30 days mortality following isolated CABG at a reference center in Algiers. The Parsonnet
risk score was well calibrated but was moderately discriminating. The development of a local risk score or the recalibration of recent international risk scores is necessary.
Keywords: Coronary artery bypass grafting, Decision-making, Hospital mortality, Risk prediction

1. Introduction

A

ccurate scoring models for predicting the risk
of operative mortality and morbidity are
essential for surgical decision making, informed
patient consent and healthcare management. When
validated in a local population, these risk scores can
be used as a benchmark for the assessment of the
quality of cardiac surgical services [1]. Although all
these score systems are based on patient derived
data such as age, gender and co-morbidities, they
differ by their design and by the number of clinical

and biological parameters used, which necessarily
results in a difference in their estimation and in
their validation. Selection of appropriate score systems among those commonly used, or the development of a loco-regional risk score, has become an
absolute necessity.
Currently, more than 20 models of risk stratiﬁcation
have been developed to predict short-term morbidity
and mortality after cardiac surgery. The pioneer in
this ﬁeld was the Parsonnet risk score, which was
described in 1989 [2]. This useful score has been
rapidly adopted by several cardiac surgery teams,
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and other authors have conﬁrmed its predictive value
on hospital mortality and morbidity [3]. The modiﬁed
2000 Bernstein-Parsonnet algorithm, which is a
simpliﬁed model [4], showed a good correlation between predicted and observed mortality in patients
undergoing CABG (on and off pump).
The European System for Cardiac Operative Risk
Evaluation (EuroSCORE), in its initial additive
version [5] was developed between 1995 and 1999,
and has gained wide acceptance in Europe, North
America and Asia. This additive model of EuroSCORE was followed by a logistic version which was
developed in 2003 to improve its tendency to underestimate the risk in high-risk patients [6]. After losing
its calibration, this score was updated in 2011 and was
called EuroSCORE II, which is currently one of the
most commonly used scores in the world [1].
In 2008, the American Society of Thoracic Surgeons developed its own logistic model, which has
been called the Society of Thoracic Surgeons Predicted Risk Of Mortality (STS-PROM) [7e9]. This
risk stratiﬁcation model is widely used in North
America and received a stronger recommendation
than that of EuroSCORE II, by the 2018 European
Society of Cardiology and the European Association
of Cardio-Thoracic Surgery guidelines on myocardial revascularization, to calculate the risk of mortality following CABG surgery [10].
The need to update regularly these risk scoring
systems, within the populations on which they were
originated, require external validation for other
populations, before certifying their applicability,
predictability, and accuracy beyond the European
and American boundaries [11].
Given the absence of a loco-regional score, we
aimed to assess the performance of the Euroscore II;
the STS-PROM, and the Parsonnet risk score, for
patients undergoing isolated CABG in Algeria.

2. Methods
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List of abbreviations
Area Under the receiver operating characteristic
Curve
BITA
Bilateral Internal Thoracic Artery
BMI
Body-Mass Index
CABG
Coronary Artery Bypass Grafting
CPB
Cardio-Pulmonary Bypass
EuroSCORE II
European System for Cardiac Operative
Risk Evaluation II
LVEF
Left Ventricular Ejection Fraction
NYHA New York Heart Association
STS-PROM
Society of Thoracic Surgeons Predicted
Risk Of Mortality
AUC

riskcalc.sts.org/stswebriskcalc/calculate. No patient
was excluded from analysis due to missing data. The
outcome of interest was the operative mortality
which includes all in-hospital deaths and deaths
occurring within 30 days of the procedure.
All procedures performed in this study involving
human participants were in accordance with the
ethical standards of the Faculty of Medicine of
Algiers and with the 1964 Helsinki declaration and
its later amendments.
The study was approved in 2014 by the institutional review board of the Faculty of Medicine of
Algiers.
Written and informed consent for coronary
artery bypass surgery was obtained from all
participants.
2.2. Inclusion and exclusion criteria
We included all consecutive patients who underwent isolated CABG (with or without the use of
cardiopulmonary bypass) between June 2014 and
June 2016.
Exclusion criteria: Association to another cardiac
surgical procedure.

2.1. Type of the study

2.3. Statistical analysis

This is a monocentric, prospective and observational study. After obtaining approval from the
Ethics Committee, we prospectively enrolled, between June 2014 and June 2016, 235 consecutive
patients undergoing isolated CABG at a reference
center in Algiers. Data acquisition was done from
patient records, and the calculation of EuroSCORE
II, STS-PROM and the initial logistic Parsonnet risk
score has been done on their respective website
(Parsonnet risk score: https://sfar.org/scores/
parsonnet.php,
EuroSCOREII:
http://www.
euroscore.org/calc.html,
STS-PROM:
https://

Statistical analyses were performed with SPSS
version 19.0 (SPSS Inc., Chicago, Illinois). Continuous variables were expressed as mean and standard deviation, and categorical variables were
expressed as percentages. A P value of less than 0.05
was considered signiﬁcant.
The risk models performances were evaluated in
terms of discrimination and calibration.
The discriminating power of these three risk
scores (statistical accuracy) was tested by calculating
the areas under the receiver operating characteristic
curve (AUC), which assessed how well the model
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could discriminate between survivors and non-survivors. The AUC value ranges from 0.5 (no ability to
discriminate) to 1.0 (full ability to discriminate). The
discriminating power of the model is considered
reasonable when the AUC is greater than 0.7 and
strong when the AUC exceeds 0.8. AUCs were
compared using the method proposed by DeLong's
test.
Calibration (statistical precision) represents the
agreement between observed and predicted
outcome. It was tested, for these risk scores, by the
HosmereLemeshow
goodness-of-ﬁt
statistics,
which performs a c2 test comparing the observed
and expected data, which have been previously
divided into deciles of risk. A well-calibrated model
gives a P value greater than 0.05.

3. Results
All 235 patients undergoing isolated CABG, between June 2014 and June 2016 were prospectively
studied. The mean patients age was 59.1 ± 9.6
(37e82), and 18.3% were female. In this cohort,
68.1% of patients had hypertension, 61.7% had diabetes mellitus, 23.4% presented extracardiac arteriopathy, and 25.5% have had a myocardial
infarction within the past 03 months. A left ventricular ejection fraction (LVEF)˂50% was noted in
29.4% (n ¼ 69) of patients. Most of the patients (60%,
n ¼ 141) had three-vessel diseases and 21.3%
(n ¼ 50) of them had left main disease. Bilateral
internal thoracic artery grafting was performed in
59.6% (n ¼ 140) of patients and the mean of the
distal anastomoses was 2.4 ± 0.8/patient (1e5)
(Table 1).

Table 1. Clinical and operative baseline characteristics of CABG
patients.
Risk factors

Patients (N ¼ 235)

Male sex. %(N)
Age (Year).
Hypertension. % (N)
Diabetes mellitus % (N)
Previous smoker. %(N)
Hyperlipidemia. %(N)
BMI 30 kg/m2
Previous Myocardial Infarction. %(N)
Myocardial Infarction <3 months. %(N)
Previous stroke. %(N)
Extracardiac arteriopathy %(N)
Chronic lung disease % (N)
Creatinine clearance ml/mn
Stable angina %(N)
Unstable angina %(N)
NYHA class I %(N)
NYHA class II %(N)
NYHA class III %(N)
LVEF %(N)
Pulmonary artery systolic
pressure (mmHg)
Left main disease %(N)
Three-vessel disease %(N)
Number of distal anastomoses
BITA grafting %(N)
CPB time (minute)
Aortic cross-clamp time (minute)

81.7 (192)
59.1 ± 9.6 (37e82)
68.1 (160)
61.7 (145)
59.1 (139)
57.9 (136)
27.7 ± 3.8 (19e38)
75.3 (177)
25.5 (60)
5.1 (12)
23.4 (55)
4.7 (11)
93.8 ± 28.1 (33e190)
83.8 (197)
16.2 (38)
43 (101)
53.6 (126)
3.4 (8)
55.4 ± 12 (24e80)
26.5 ± 7.3 (15e60)
21.3 (50)
60 (141)
2.4 ± 0.8 (1e5)
59.6 (140)
84 ± 33.6 (25e166)
63.6 ± 24.7 (15e110)

Abbreviations: BITA: Bilateral internal thoracic artery. BMI:
Body-Mass Index, CPB: Cardiopulmonary bypass, LVEF: Left
Ventricle Ejection Fraction, NYHA: New York Heart Association.

The comparison between the discriminating
powers, using the De Long's test for two receiver
operating characteristic curves, showed that the
EuroSCORE II outperformed signiﬁcantly the STSPROM (0.893 versus 0.788. 95% Conﬁdence Interval:
0.004e0.204, P ¼ 0.041).

3.1. Overall mortality

3.3. Calibration

There were 8 deaths observed, giving an overall
observed mortality at 30 days of 3.40%. Predicted
mortality rate for the EuroSCORE II, STS-PROM,
and Parsonnet risk score were 1.33% þ/0.95%,
0.78% þ/ 0.96%, and 3.35% þ/ 2.44%, respectively (Fig. 1).

EuroSCORE II and STS-PROM achieved bad calibrations and underestimated the observed mortality (HosmereLemeshow statistic was: 37.96, p˂
0.0001 and 72.14, p˂ 0.0001, respectively), while the
Parsonnet risk score was well calibrated (HosmereLemeshow statistic: 8.40, p ¼ 0.395). The
observed/expected ratio of operative mortality was
2.55, 4.36, and 1.01, respectively.
The details of the three risk scores performances
are shown in Table 2.
Calibration curve plots (Fig. 3) showed that all
scores had a relatively linear relationship between
predicted and observed mortality. While the Parsonnet risk score had good calibration regardless of
the patient's risk proﬁle, the STS-PROM underestimated mortality for all patient's risk proﬁles, and

3.2. Discrimination
EuroSCORE II achieved a strong discrimination
with an AUC ¼ 0.893 (95% Conﬁdence Interval:
0.798e0.987), followed by STS-PROM (AUC ¼ 0.788.
95% Conﬁdence Interval: 0.617e0.959) then by Parsonnet risk score (AUC ¼ 0.737. 95% Conﬁdence
Interval: 0.520e0.953), whose discrimination was fair
(Fig. 2).
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Fig. 1. Distribution of mortality rates estimated by EuroSCORE II, STS PROM and Parsonnet score.The red line indicates the average observed
mortality.

Fig. 2. Receiver operating characteristics (ROC) curves of the three scoring models for patients undergoing CABG in Algiers. The area under the curve
ROC (AUC) of EuroSCORE II was 0.893 (95% CI: 0.798e0.987), of STS-PROM was 0.788 (95% CI: 0.617e0.959), and of -Parsonnet score was
0.737 (95% CI: 0.520e0.953).
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Table 2. Predictive performances of the three risk scores for patients undergoing isolated CABG in Algeria.

EuroSCORE II
STS-PROM
Parsonnet risk score

Observed
mortality

Predicted
mortality

AUC
(95% Conﬁdence interval)

HosmereLemeshow
test (P value)

Observed mortality/
Predicted mortality

3.40%
3.40%
3.40%

1.33% ± 0.95%
0.78% ± 0.96%
3.35% ± 2.44%

0.893 (0.798e0.987)
0.788. (0.617e0.959)
0.737. (0.520e0.953)

p<0.0001
p<0.0001
P ¼ 0.395

2.55
4.36
1.01

Abbreviations: AUC: area under the receiver operator characteristics curve; CI: conﬁdence interval.

Fig. 3. Calibration plots for the three risk scoring models.The diagonal line represents the perfect calibration line. (Blue) for Parsonnet score. (Red) for
EuroSCORE II. (Green) for STS-PROM.

the EuroSCORE II only underestimated it for patients whose expected mortality was greater than
2%.

4. Discussion
The main conclusions of this prospective monocentric study, concerning patients undergoing isolated CABG at a reference center in Algiers, are:
 EuroSCORE II and STS-PROM, which are the
most widely used risk scoring systems worldwide, had excellent and good discrimination,
respectively, but both underestimated the risk of
30 days mortality.
 The initial logistic Parsonnet risk score had fair
discrimination but perfect calibration.
The excellent and good discriminating power of
EuroSCORE II and STS PROM, compared to the fair

accuracy of Parsonnet risk score, means that the
design of these two models and the greater number
of variables they contain make them more accurate
in identifying patients at high, intermediate or low
risk of mortality. However, the lack of precision of
these two recent risk scores, reﬂecting the current
and efﬁcient European and united states health
systems, in estimating the mortality of Algerian
CABG-patients; is due to the higher than expected
mortality rate in our cohort which was closer to that
expected by Parsonnet risk score.
A calibration failure can be explained by differences in the patients risk proﬁle, but also by a
deﬁciency in the quality of care, which depends
closely on socio-economic conditions, surgical
technique and quality of postoperative care, or by a
poor design of the predictive model.
Compared with EuroSCORE II database patients,
our cohort included many more patients with

mellitus diabetes (þ36.7%), with an average Glycosylated hemoglobin of 8.2 ± 1.7%. This may partly
explain the fact that our patients, of which 25.5%
had MI within the last 90 days, required coronary
bypass surgery at a younger age (5.5 years).
The stability and quality of isolated CABG outcomes clearly depends on both the annual volume
of the center and that of the surgeons. Like other
Algerian public cardiac surgery departments
(n ¼ 7), our center has a relatively low experience in
CABG surgery, with less than 120 patients/year.
This is partly explained by the distribution of patients through a larger number of private hospitals
(n ¼ 17), but also by the fact that our population is
still experiencing an epidemiological transition
recording more and more coronary artery diseases
without reaching yet the high western incidence of
this disease.
Thus, the distribution of patients across many
centers will not allow any of them to be a high
volume center with a high degree of expertise to
reach the western level of performance. This may be
one of the reasons limiting the validation of these
recent international risk scores in developing
countries, where the majority of centers have a low
volume of procedures.
Our patients were operated on by 4 surgeons,
working in pairs on all procedures. Our surgical
team has favored the bilateral internal thoracic artery (BITA) grafting in its different conﬁgurations,
insitu-BITA, BITA-Y composite grafts, as well as the
different types of sequential anastomoses performed in the classic way or in diamond. BITA
grafting was performed in 59.6% of patients while
total arterial grafting was performed in 35.3% of
patients. At the beginning of the study period, 02
surgeons were already experienced and had already
performed more than 100 CABG while the others
had performed less than 50 CABG. Of note, epiaortic ultrasound, transit-time ﬂow measurement of
coronary artery bypass grafts and the various mechanical circulatory supports, which can signiﬁcantly reduce CABG morbidity and mortality, are
still not available in our center or in any other cardiac surgery center in across the country. The lack of
modern equipments added to the lurning curve of
certain surgeons certainly inﬂuenced the operative
mortality of our study.
External validation of EuroSCORE II and STSPROM for patients with isolated CABG has been
performed on many ethnically different populations, whose lifestyles and eating habits tend to
mimic the western model, such in China [12] and
Malaysia [13]. However, in developing countries,
these risk scores, which were established on
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European and North American populations, seem
inappropriate for estimating operative mortality
following CABG. This is due not only to ethnic and
epidemiological factors, but also to differences in
the quality of control of cardiovascular diseases risk
factors and in the quality of intra-hospital care,
which necessarily lead to different outcomes.
Thus in a Brazilian retrospective cohort study of
1,065 patients, 2000 Bernstein-Parsonnet score and
EuroSCORE I showed good discriminatory power,
but underestimated the in-hospital mortality. This
result was in contradiction with what has been
observed, during the same period, when applying
these two scores in developed countries [14].
Furthermore, in a more recent cohort of 5,222 Brazilian patients, including 60% of patients who
beneﬁted from a CABG, the regional score outperformed the STS-PROM and the EuroSCORE II,
which also greatly underestimated the observed
mortality [15]. The calibration curves of the EuroSCORE II and STS-PROM of this Brazilian cohort
are in perfect adequacy with those generated by our
study.
The same conclusion was made for EuroSCORE II
in India [16], and Turkey [17]. Even the logistics
EuroSCORE, who is known for its overestimation of
the risk in European populations, was not applicable
in an Iranian study including 2220 CABG procedures [18].
Concerning the predictive performances over
time of these scoring systems, it has been noted
that Parsonnet risk score, STS-PROM, and EuroSCORE have experienced a progressive loss of
their calibration, even in the populations where
they have been established. Indeed, these models
overestimated the risk as the results of cardiac
surgery have substantially improved with a sustained reduction of risk-adjusted mortality [1]. In
addition, EuroSCORE II has been criticized since
its publication. Its innate tendency to underestimate observed mortality was considered "acceptable" by authors of the original publication,
although its calibration was controversial, since the
value of the goodness-of-ﬁt test was near the failure in the original internal validation (p ¼ 0.0505)
[1]. This has led to validation concerns of EuroSCORE II in countries that participated in its
development, such as Canada [19] and the United
Kingdom [20] where this model was poorly calibrated and failed the HosmereLemeshow test in
cohorts of isolated CABG patients (P ¼ 0.002,
P < 0.001, respectively).
Since international scores are not applicable in all
countries, some national scores have emerged, and
were validated on their respective populations, such
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as the Chinese [12], or the Australian System for
Cardiac Operative Risk Evaluation [21] or the S~
ao
Paulo risk Score for Brazil [15].

[2]

5. Limitations
The major limitations of this study are the small
sample size and the single-centre design, which
may affect the generalizability of results to the entire
country. Our relatively low annual volume of CABG
procedures may have affected the prediction precision of EuroSCORE II and STS-PROM which also
showed good accuracy. A multicentre study conducted over a longer period will make it possible to
collect a larger sample size of patients in order to
improve the power of the study and to validate or
not the applicability of these universal tools of risk
scoring at the country scale.

[3]

[4]

[5]

[6]
[7]

6. Conclusions
EuroSCORE II and STS-PROM had good
discriminating power, but both underestimated the
risk of 30 days mortality following isolated CABG at
a reference center in Algiers. The Parsonnet risk
score was well calibrated but was moderately
discriminating. The development of a local risk
score or the recalibration of recent international risk
scores is necessary to better assess the risk.
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